Hemagglutinins
Showing 1 - 25 of 34
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Influenza Trial in Novosibirsk (Flu-M Quadro [inactivated split influenza vaccine] with preservative, Flu-M Quadro [inactivated
Completed
- Influenza
- Flu-M Quadro [inactivated split influenza vaccine] with preservative
- +2 more
-
Novosibirsk, Russian FederationFederally Funded Healthcare Institution Primary Healthcare Unit
Dec 16, 2021
Flu Vaccine Trial in Nashville (Fluzone-High Dose Quadrivalent, Fluad, Flublock)
Completed
- Flu Vaccine
- Fluzone-High Dose Quadrivalent
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 16, 2022
Influenza, Seasonal Influenza Trial run by the NIAID (VRC-FLUMOS0111-00-VP (FluMos-v1), Flucelvax)
Active, not recruiting
- Influenza
- Seasonal Influenza
- VRC-FLUMOS0111-00-VP (FluMos-v1)
- Flucelvax
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Influenza Trial in New Haven (Fluzone, Fluad)
Not yet recruiting
- Influenza
- Fluzone
- Fluad
-
New Haven, Connecticut
- +1 more
Mar 15, 2022
Immunological Pure Red Cell Aplasia Trial (Isatuximab)
Not yet recruiting
- Immunological Pure Red Cell Aplasia
- (no location specified)
Sep 26, 2022
Scar Trial in Cleveland, Westlake (Dysport (abobotulinumtoxinA), Bacteriostatic 0.9% Sodium Chloride (vehicle))
Terminated
- Scar
- Dysport (abobotulinumtoxinA)
- Bacteriostatic 0.9% Sodium Chloride (vehicle)
-
Cleveland, Ohio
- +1 more
Apr 29, 2022
Influenza, Influenza-like Illness, Influenza Vaccines Trial in United States (Egg based influenza vaccines, Recombinant
Recruiting
- Influenza
- +2 more
- Egg based influenza vaccines
- +2 more
-
San Diego, California
- +8 more
Dec 22, 2021
Influenza, Human Trial in Hong Kong (Standard inactivated influenza vaccine (NH formulation), MF 59 adjuvanted inactivated
Active, not recruiting
- Influenza, Human
- Standard inactivated influenza vaccine (NH formulation)
- +3 more
-
Hong Kong, ChinaThe University of Hong Kong
Sep 24, 2021
Influenza (Healthy Volunteers) Trial in Worldwide (Standard-Dose influenza virus surface antigens (haemagglutinin and
Completed
- Influenza (Healthy Volunteers)
- Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)
- High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northern Hemisphere formulation
-
Gent, Belgium
- +16 more
Mar 24, 2022
Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)
Completed
- Influenza
- FluBlok
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Vaccine Research Unit Ro
Nov 1, 2021
Influenza, Human Trial in Mexico (Study group - quadrivalent recombinant hemagglutinin influenza vaccine, Control group -
Completed
- Influenza, Human
- Study group - quadrivalent recombinant hemagglutinin influenza vaccine
- Control group - quadrivalent inactivated influenza vaccine
-
Saltillo, Coahuila, Mexico
- +10 more
Nov 12, 2019
Urinary Incontinence, Overactive Bladder Trial in Worldwide (Botulinum toxin type A, Placebo)
Terminated
- Urinary Incontinence
- Overactive Bladder
- Botulinum toxin type A
- Placebo
-
Birmingham, Alabama
- +80 more
Jul 1, 2021
Urinary Incontinence, Overactive Bladder Trial in Worldwide (Botulinum toxin type A, Placebo)
Terminated
- Urinary Incontinence
- Overactive Bladder
- Botulinum toxin type A
- Placebo
-
Buenos Aires, Argentina
- +81 more
Jul 1, 2021
Hallux Abducto Valgus Trial in United States (Botulinum toxin type A, Placebo)
Completed
- Hallux Abducto Valgus
- Botulinum toxin type A
- Placebo
-
Jonesboro, Arkansas
- +28 more
Jul 1, 2021
Influenza, Avian Trial in Adelaide (Recombinant influenza hemagglutinin)
Completed
- Influenza, Avian
- Recombinant influenza hemagglutinin
-
Adelaide, South Australia, AustraliaFlinders University
May 6, 2019
Influenza Trial in Adelaide (recombinant influenza hemagglutinin, Advax1, Advax2)
Completed
- Influenza
- recombinant influenza hemagglutinin
- +2 more
-
Adelaide, South Australia, AustraliaFlinders University
May 6, 2019
Hematopoietic Stem Cell Transplant, Hematologic Malignancy Trial in Minneapolis (Influenza vaccine)
Terminated
- Hematopoietic Stem Cell Transplant
- Hematologic Malignancy
- Influenza vaccine
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Influenza Trial in Auburn (Flublok® Quadrivalent Influenza Virus Vaccine, Fluarix Quadrivalent® Influenza Virus Vaccine)
Completed
- Influenza
- Flublok® Quadrivalent Influenza Virus Vaccine
- Fluarix Quadrivalent® Influenza Virus Vaccine
-
Auburn, MaineMaine Research Associates, LLC
Aug 2, 2016
Influenza, Pandemic Influenza Trial in United States (H5N1 Influenza Vaccine, Whole virion, Vero cell-derived, Inactivated
Completed
- Influenza
- Pandemic Influenza
- H5N1 Influenza Vaccine, Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted (reverse genetic reassortant/H5N1 hemagglutinin antigen)
-
Wichita, Kansas
- +5 more
Oct 7, 2015
Influenza Trial in Hong Kong, Shatin, Singapore (Whole virion, Vero cell-derived influenza vaccine containing either 3.75 µg or
Completed
- Influenza
- Whole virion, Vero cell-derived influenza vaccine containing either 3.75 µg or 7.5 µg H5N1 hemagglutinin (HA) antigen in a non-adjuvanted formulation
-
Hong Kong, Hong Kong
- +3 more
Oct 7, 2015